Table 1.

Outcome of COVID-19 in cladribine-treated patients

n° COVID-19 patients treated with Cladribine	No. of patients (%) with COVID-19 clinical manifestations severity	References
3	3 (100%): not severe/fatal	[42]
11	11 (100%): not hospitalized	[43]
27	2 (7.4%): hospitalized; 0 (0%): ICU; 0 (0%): ventilation; 0 (0%): death	[44]
25	19 (76%): not hospitalized/mild symptoms; 6 (24%): hospitalized, not ventilated; 0 (0%): ventilated; 0 (0%): death	[45]
21	19 (90.5%): mild symptoms; 2 (9.5%): moderate, no severe/fatal	[46]
2	2 (100%): mild/self-limiting	[48]
2	2 (100%): mild/asymptomatic	[50]

ICU intensive care unit